Ionescu, D. F., Rosenbaum, J. F., & Alpert, J. E. (2015). Pharmacological approaches to the challenge of treatment-resistant depression. Dialogues in clinical neuroscience, 17(2), 111–126.

Balasubramanian, B. A., Cohen, D. J., Jetelina, K. K., Dickinson, L. M., Davis, M., Gunn, R., Gowen, K., deGruy, F. V., 3rd, Miller, B. F., & Green, L. A. (2017). Outcomes of Integrated Behavioral Health with Primary Care. Journal of the American Board of Family Medicine : JABFM, 30(2), 130–139.

Depression Screening Rates in Primary Care Remain Low. American Psychiatric Association. (2017, February 15). Retrieved October 13, 2021, from

Panchal, N., Kamal, R., Cox, C., & Garfield, R. (2021, February 10). The Implications of COVID-19 for Mental Health and Substance Use. KFF.

Barkil-Oteo A. (2013). Collaborative care for depression in primary care: how psychiatry could “troubleshoot” current treatments and practices. The Yale journal of biology and medicine, 86(2), 139–146.

Ferguson J. M. (2000). Depression: Diagnosis and Management for the Primary Care Physician. Primary care companion to the Journal of clinical psychiatry, 2(5), 173–178.

Combs, H., & Markman, J. (2014). Anxiety Disorders in Primary Care. Medical Clinics of North America, 98(5), 1007–1023.

Siu, A. L., US Preventive Services Task Force (USPSTF), Bibbins-Domingo, K., Grossman, D. C., Baumann, L. C., Davidson, K. W., Ebell, M., García, F. A., Gillman, M., Herzstein, J., Kemper, A. R., Krist, A. H., Kurth, A. E., Owens, D. K., Phillips, W. R., Phipps, M. G., & Pignone, M. P. (2016). Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement. JAMA, 315(4), 380–387.